These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

733 related articles for article (PubMed ID: 29536376)

  • 1. Comparison of sentinel lymph node biopsy between invasive lobular carcinoma and invasive ductal carcinoma.
    Adachi Y; Sawaki M; Hattori M; Yoshimura A; Gondo N; Kotani H; Iwase M; Kataoka A; Onishi S; Sugino K; Terada M; Horisawa N; Mori M; Oze I; Iwata H
    Breast Cancer; 2018 Sep; 25(5):560-565. PubMed ID: 29536376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between sentinel lymph node biopsy and non-sentinel lymph node metastasis in patients with cN0 breast carcinoma: comparison of invasive ductal carcinoma and invasive lobular carcinoma.
    Cipolla C; Lupo S; Grassi N; Tutino G; Greco M; Eleonora D; Gebbia V; Valerio MR
    World J Surg Oncol; 2024 Apr; 22(1):100. PubMed ID: 38627759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel Lymph Node Biopsy and Isolated Tumor Cells in Invasive Lobular Versus Ductal Breast Cancer.
    Truin W; Roumen RM; Siesling S; van der Heiden-van der Loo M; Lobbezoo DJ; Tjan-Heijnen VC; Voogd AC
    Clin Breast Cancer; 2016 Aug; 16(4):e75-82. PubMed ID: 27116948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors predicting the non-sentinel lymph node involvement in breast cancer patients with sentinel lymph node metastases.
    Boler DE; Uras C; Ince U; Cabioglu N
    Breast; 2012 Aug; 21(4):518-23. PubMed ID: 22410110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sensitivity of pre-operative axillary staging in breast cancer: comparison of invasive lobular and ductal carcinoma.
    Topps A; Clay V; Absar M; Howe M; Lim Y; Johnson R; Bundred N
    Eur J Surg Oncol; 2014 Jul; 40(7):813-7. PubMed ID: 24797703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axillary lymph node and non-sentinel lymph node metastasis among the ACOSOG Z0011 eligible breast cancer patients with invasive ductal, invasive lobular, or other histological special types: a multi-institutional retrospective analysis.
    Gao W; Zeng Y; Fei X; Chen X; Shen K
    Breast Cancer Res Treat; 2020 Nov; 184(1):193-202. PubMed ID: 32740809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative evaluation of sentinel lymph nodes in invasive lobular carcinoma of the breast.
    Taras AR; Hendrickson NA; Pugliese MS; Lowe KA; Atwood M; Beatty JD
    Am J Surg; 2009 May; 197(5):643-6; discussion 646-7. PubMed ID: 19393357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of intraoperative frozen section analysis for sentinel lymph node biopsy during breast cancer surgery for invasive lobular carcinoma and invasive ductal carcinoma.
    Horvath JW; Barnett GE; Jimenez RE; Young DC; Povoski SP
    World J Surg Oncol; 2009 Mar; 7():34. PubMed ID: 19317888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lobular Histology Does Not Predict the Need for Axillary Dissection Among ACOSOG Z0011-Eligible Breast Cancers.
    Mamtani A; Zabor EC; Stempel M; Morrow M
    Ann Surg Oncol; 2019 Oct; 26(10):3269-3274. PubMed ID: 31342363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role for sentinel lymph node dissection in the management of large (> or = 5 cm) invasive breast cancer.
    Chung MH; Ye W; Giuliano AE
    Ann Surg Oncol; 2001 Oct; 8(9):688-92. PubMed ID: 11597008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Dutch Prediction Tool to Assess the Risk of Additional Axillary Non-Sentinel Lymph Node Involvement in Sentinel Node-Positive Breast Cancer Patients.
    van den Hoven I; van Klaveren D; Voogd AC; Vergouwe Y; Tjan-Heijnen V; Roumen RM
    Clin Breast Cancer; 2016 Apr; 16(2):123-30. PubMed ID: 26602438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of nonsentinel lymph node metastasis in breast cancer patients with one or two positive sentinel lymph nodes.
    Öz B; Akcan A; Doğan S; Abdulrezzak Ü; Aslan D; Sözüer E; Emek E; Akyüz M; Elmalı F; Ok E
    Asian J Surg; 2018 Jan; 41(1):12-19. PubMed ID: 27591153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperative assessment of sentinel lymph node by one-step nucleic acid amplification in breast cancer patients after neoadjuvant treatment reduces the need for a second surgery for axillary lymph node dissection.
    Espinosa-Bravo M; Navarro-Cecilia J; Ramos Boyero M; Diaz-Botero S; Dueñas Rodríguez B; Luque López C; Ramos Grande T; Ruano Perez R; Peg V; Rubio IT
    Breast; 2017 Feb; 31():40-45. PubMed ID: 27810698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of sentinel lymph node biopsy and non-sentinel lymph node metastasis in invasive ductal and invasive lobular breast cancer: a nationwide cross-sectional study (CSBrS-001).
    Zhang J; Ling Y; Wang T; Yan C; Huang M; Fan Z; Ling R;
    Ann Transl Med; 2021 Oct; 9(20):1588. PubMed ID: 34790794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a breast cancer nomogram for predicting nonsentinel node metastases after minimal sentinel node involvement: validation of the Helsinki breast nomogram.
    Ouldamer L; Arbion F; Balagny A; Fourquet F; Marret H; Body G
    Breast; 2013 Oct; 22(5):787-92. PubMed ID: 23473772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
    Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
    Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of Clinical Value for Immunohistochemistry for Sentinel Lymph Node Assessment in Invasive Lobular Carcinoma.
    Sanders SB; Hoskin TL; Solanki MH; Stafford AP; Boughey JC; Hieken TJ
    Ann Surg Oncol; 2022 Oct; 29(10):6458-6465. PubMed ID: 35849283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node biopsy in patients with operable breast cancer treated with neoadjuvant chemotherapy.
    Rebollo-Aguirre AC; Gallego-Peinado M; Menjón-Beltrán S; García-García J; Pastor-Pons E; Chamorro-Santos CE; Ramos-Font C; Salamanca-Ballesteros A; Llamas-Elvira JM; Olea-Serrano N
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):117-23. PubMed ID: 21676504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
    Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
    Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors for additional non-sentinel lymph node involvement in breast cancer patients with one positive sentinel node.
    Meattini I; Saieva C; Bertocci S; Francolini G; Zei G; De Luca Cardillo C; Scotti V; Greto D; Bonomo P; Orzalesi L; Bianchi S; Livi L
    Tumori; 2015; 101(1):78-83. PubMed ID: 25702658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.